We resume our conversation with Prof Eric Morand on lupus. In part 1, we talked about the progress in understanding disease mechanisms, and how this progress can now lead to the development of therapies. So we'll learn more about the clinical targets now being pursued and how for the first time lupus patients can imagine being treated with better drugs, for better disease outcome and management.